4SI
All evidence
Curated Flagship CaseScore 95 / CRITICAL

False CE markings put unassessed feeding devices into neonatal care

OCCURREDJul 1, 2026
DOMAINObject Presence & Authenticity
EVIDENCE ASSURANCEA / Direct institutional record
SOURCEUK Medicines and Healthcare products Regulatory Agency

01 / EXECUTIVE SUMMARY

What the evidence
establishes.

The MHRA secured fraud convictions relating to medical devices supplied with false CE markings; enteral feeding pumps were used in neonatal and special-care baby units without required assessment, clinical evaluation or safety testing.

02 / WHAT HAPPENED

From accepted signal
to real consequence.

The MHRA secured fraud convictions relating to medical devices supplied with false CE markings; enteral feeding pumps were used in neonatal and special-care baby units without required assessment, clinical evaluation or safety testing.

03 / CLAIM-TO-CONSEQUENCE CHAIN

Four stages.
One missing boundary.

The chain distinguishes what appeared valid, what was physically true, which authority followed and what consequence the source documents.

01 / DIGITAL CLAIM

What appeared valid.

CE markings and supplier representations claimed the devices had valid regulatory approval and met safety requirements.

02 / PHYSICAL REALITY

What was present.

The MHRA found the markings invalid and the pumps had not undergone required assessments, clinical evaluation or safety testing.

03 / AUTHORITY & ACTION

What proceeded.

NHS trusts placed the devices into use in hospitals, including neonatal intensive-care and special-care baby units.

04 / DOCUMENTED IMPACT

What the source records.

The devices were recalled and removed from UK and EU markets; the release does not quantify patient injuries.

MISSING TRUST BOUNDARY / 4SI ANALYSIS

Regulator-verifiable binding among approval record, manufacturer, model and each physical device before clinical use.

04 / ECONOMIC CONSEQUENCE RANGE

Evidence before
false precision.

ECR separates a documented monetary floor from a modeled social and economic consequence envelope. It is not an accounting loss figure.

MODELED CONSEQUENCE RANGE

$15.6K–$594K

$96.3KCentral modeled position · USD equivalent
DOCUMENTED FLOOR$0
DATA COVERAGE40%
MODEL MODEproxy led
METHODECR 1.0
UNCERTAINTY

Public evidence does not disclose a monetary amount or affected population; the range is therefore prior-led and deliberately wide.

05 / 4SI ANALYSIS

Source fact and inference
remain separate.

Convictions, device use and regulatory failures are MHRA facts. The Presence Risk interpretation is 4SI analysis.

CONNECTION TO THE PRESENCE THESIS

A conformity mark can carry authority while the physical product behind it remains unverified.

ANALYTICAL LIMITATION

4SI does not claim to have independently verified the underlying event. Scores, boundary analysis and economic ranges interpret published evidence; they are not probabilities, compliance findings, valuations or loss forecasts.

FROM EVIDENCE TO CONTROL

Presence belongs at the
moment of consequence.